文献速递创伤与烧伤

下肢穿透伤常规CTA的成本效益分析

Cost-effectiveness analysis of routine computed tomography angiography (CTA) for lower extremity penetrating trauma.
PubMed 文献 · Am J Emerg Med · 2024-05-11
一句话结论孤立性下肢穿透伤且ABI与临床检查正常者,常规CTA不具成本效益,无获益且费用增加。

本研究采用决策分析模型,比较血流动力学稳定的孤立性下肢穿透伤且ABI正常患者常规CTA与临床观察加ABI评估的成本效益。结果显示,仅临床评估(不做CTA)具成本效益,成本2056.13美元、获得0.98 QALYs;常规CTA成本7449.91美元、QALYs 0.92。单因素敏感性分析显示,只有当漏诊损伤的成本达到210075.83美元时,常规CTA才成为具成本效益的策略。作者结论认为,此类患者不 warrant 常规CTA。

要点

  • 孤立性下肢穿透伤、ABI正常(≥0.9)且临床检查正常、血流动力学稳定者,仅临床评估(不做CTA)成本2056.13美元、0.98 QALYs,具成本效益。
  • 同组患者常规CTA成本7449.91美元、QALYs 0.92,费用更高且QALYs更低。
  • 单因素敏感性分析:漏诊损伤成本需达210075.83美元,常规CTA才成为具成本效益策略。
  • 作者结论:此类患者不 warrant 常规CTA,因无获益且费用增加。

适用人群与场景

  • 血流动力学稳定的孤立性下肢穿透伤患者,且踝臂指数(ABI)正常(≥0.9)、临床检查正常。

诊断标准与关键阈值

  • ABI正常定义为≥0.9。

处置流程与药物剂量

  • 对于血流动力学稳定的孤立性下肢穿透伤且ABI正常、临床检查正常者,仅临床观察加ABI评估(不做常规CTA)为具成本效益策略。

研究设计与关键结果

  • 决策分析模型比较常规CTA与临床观察加ABI评估的成本效益;基础病例为在创伤抢救室接受CTA的孤立性下肢穿透伤且ABI正常患者。
  • 仅临床评估(不做CTA)成本2056.13美元、获得0.98 QALYs,具成本效益。
  • 常规CTA成本7449.91美元、QALYs 0.92,费用更高且QALYs更低。
  • 单因素敏感性分析:漏诊损伤成本达210075.83美元时,常规CTA才成为具成本效益策略。

证据类型、等级与局限

  • 证据类型:决策分析模型(成本效益分析),成本和概率及QALYs来自已发表文献。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,孤立性下肢穿透伤且ABI正常、临床检查正常的患者不 warrant 常规CTA,因无获益且费用增加。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Routine evaluation with CTA for patients with isolated lower extremity penetrating trauma and normal ankle-brachial-indices (ABI) remains controversial. While prior literature has found normal ABI's (≥0.9) and a normal clinical examination to be adequate for safe discharge, there remains concern for missed injuries which could lead to delayed surgical intervention and unnecessary morbidity. Our hypothesis was that routine CTA after isolated lower extremity penetrating trauma with normal ABIs and clinical examination is not cost-effective.

METHODS: We performed a decision-analytic model to evaluate the cost-effectiveness of obtaining a CTA routinely compared to clinical observation and ABI evaluation in hemodynamically normal patients with isolated penetrating lower extremity trauma. Our base case was a patient that sustained penetrating lower extremity trauma with normal ABIs that received a CTA in the trauma bay. Costs, probability, and Quality-Adjusted Life Years (QALYs) were generated from published literature.

RESULTS: Clinical evaluation only (no CTA) was cost-effective with a cost of $2056.13 and 0.98 QALYs gained compared to routine CTA which had increased costs of $7449.91 and lower QALYs 0.92. Using one-way sensitivity analysis, routine CTA does not become the cost-effective strategy until the cost of a missed injury reaches $210,075.83.

CONCLUSIONS: Patients with isolated, penetrating lower extremity trauma with normal ABIs and clinical examination do not warrant routine CTA as there is no benefit with increased costs.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Alcasid NJ, Susai CJ, Banks KC, et al. Cost-effectiveness analysis of routine computed tomography angiography (CTA) for lower extremity penetrating trauma. Am J Emerg Med. 2024. PMID: 38772156. doi:10.1016/j.ajem.2024.05.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。